Skip to content

Epidaurus · Treatment Guide · Diagnostic Services

Going abroad for —

Pathology Quality

Laboratory and pathology services quality

The country comparison

Which countries are best for pathology quality

The destinations ranked high→low under this lens — each with the reasoning behind its score, the cited evidence one click down, and its full report. The verdict is free; the report is the depth.

19 / 19 Countries ranked

Researched and assessed by the Epidaurus editorial pipeline against our published scale. A country below the rule is not yet assessed enough — never ranked last.

  1. 1 United Arab Emirates AE 5.0/5 Good The United Arab Emirates demonstrates world-class pathology quality across multiple dimensions. Major laboratories hold extensive international accreditations (CAP, ISO 15189, JCI, AABB), supported by a mandatory regu... Full report
    The evidence behind this score 5 cited points
    • Multiple flagship laboratories hold CAP, ISO 15189, JCI Gold Seal, and AABB accreditations simultaneously (NRL, Cleveland Clinic Abu Dhabi, Sheikh Shakhbout Medical City, Mediclinic City Hospital)
    • NRL operates 25+ pathologists and 200+ medical laboratory scientists across 12 facilities with 5,000+ available tests; all pathologists meet unified requirements for postgraduate specialist degrees or international board certification
    • State-of-the-art infrastructure includes PureHealth PureLab (70,000 sq ft facility with robotics and AI, processing 30+ million samples annually with 1,800+ test parameters) and Cleveland Clinic Abu Dhabi digital pathology with AI-powered computational diagnostics for prostate and breast cancer
    • Robust quality systems include CAP EQAS proficiency testing participation (continuous since 2002), mandatory external quality assurance per DOH/DHA standards, and multidisciplinary tumor boards active at all major oncology centers
    • Comprehensive pathology services span anatomical pathology, clinical chemistry, hematology, molecular diagnostics, genomics, transplant immunology, and newborn screening; English-language reporting standard across internationally accredited hospitals; dedicated international patient programs with multilingual support and care coordination

    Read the full United Arab Emirates report →

  2. 2 United States US 5.0/5 Good The United States demonstrates exceptional pathology quality across all measured dimensions. With CAP accrediting over 8,000 laboratories and 41 institutions maintaining continuous accreditation since 1964, the regula... Full report
    The evidence behind this score 6 cited points
    • CAP accredits more than 8,000 laboratories with standards called 'the toughest and most exacting in the medical business'; 41 labs continuously accredited since 1964
    • Diagnostic concordance rate of 99.96% at leading laboratories (Inform Diagnostics); surgical pathology error rate 0.5–1%; 40-year cumulative major discrepancy 0.9%, clinical impact 0.03%
    • FDA approved digital pathology systems in 2024 (Indica Labs HALO AP Dx, Roche Digital Pathology Dx); Mayo Clinic digitizing >50% of surgical pathology cases and 100% of dermatology cases as of January 2025
    • 18,000 board-certified pathologists via American Board of Pathology; 22 pathology subspecialties available; all certificates require Continuing Certification Program (since 2006)
    • 100,000–200,000 international patients annually; UCLA, Cleveland Clinic, UPMC, MGH, Utah actively supporting international collaborations via digital platforms; bilingual coordinators and remote second opinions available
    • CAP proficiency testing program (75 years, established 1946); 20,000+ laboratories worldwide participate; biochemical genetics PT performance: analytic sensitivities 88.2–93.4%

    Read the full United States report →

  3. 3 Germany DE 4.5/5 Good Germany demonstrates excellent pathology infrastructure with ~450 ISO 15189-accredited laboratories (all successfully transitioned to 2024 standards), multiple CAP accreditations at specialist centers, and a legally m... Full report
    The evidence behind this score 6 cited points
    • ~450 ISO 15189 accreditations with zero losses during 2024 transition; three CAP accreditations (MLM since 2014, MLL Dx since 2021, Arcensus October 2024)
    • Rili-BÄK legally mandated through Medical Devices Operator Ordinance; 1,370 laboratory inspections conducted in 2022 alone
    • INSTAND operates >350 mandatory external proficiency testing schemes; QuIP provides tissue-based pathology proficiency testing for up to 180 participating laboratories
    • Pathologist density 1:47,989 inhabitants (second-lowest in Europe vs European average 1:32,018) with documented workload pressure and only 1 of 18 surveyed institutes rating workload as 'very good'
    • EMPAIA €11.4M digital pathology initiative led by Charité; DKFZ operates NovaSeq X Plus and other world-class NGS platforms; UKE Hamburg processes >75,000 cases/year with subspecialty expertise
    • Charité and Heidelberg operate dedicated international patient departments with multilingual support (Arabic, English, Polish, Russian, Ukrainian); 27,000 international patients at Heidelberg annually

    Read the full Germany report →

  4. 4 Singapore SG 4.5/5 Good Singapore's pathology ecosystem demonstrates exceptional infrastructure and accreditation across all major hospitals (CAP, ISO 15189, RCPA), world-class pathologist training via ACGME-I and JCST with RCPA/FRCPath exit... Full report
    The evidence behind this score 5 cited points
    • SGH holds CAP accreditation since March 2003 and BSL-3 certification since December 2003; NUH dual CAP + ISO; KKH triple accreditation (SAC ISO 15189, CAP, RCPA); TTSH CAP-accredited; Innoquest only private lab with dual CAP + SAC-SINGLAS ISO 15189
    • Five-year ACGME-I and JCST-accredited residency with RCPA or FRCPath exit examinations; National Skin Centre ICDP-accredited dermatopathology fellowship; mandatory 50 CME points per 2-year certificate; NUS Pathology with 81 faculty among largest in Southeast Asia
    • SGH-Philips Digital and Computational Pathology Center of Excellence targeting ASEAN's first fully digitized histopathology; A*STAR Bioinformatics Institute AI tools (A!MagQC, A!HistoClouds, A!Prostate) deployed at NUH, SGH, TTSH; TTSH CAP-accredited NGS Molecular Diagnostic Laboratory
    • SGH participates in over 60 external quality assurance programs (CAP, RCPA, WHO, QCMD) spanning all pathology disciplines with Laboratory Quality Committee and critical result protocols
    • HSA achieved WHO Maturity Level 4 for medical device regulation in March 2026—first nation globally; NUH DMOC accepts overseas institutional referrals; SGH Client and Specimen Management for external specimens; English-language reporting standard but no routine multilingual translation services for non-English patients

    Read the full Singapore report →

  5. 5 Israel IL 4.5/5 Good Israel demonstrates world-leading capabilities in digital pathology and AI-assisted diagnostics, with multiple JCI-accredited major hospitals providing comprehensive pathology services and proven medical tourism outco... Full report
    The evidence behind this score 5 cited points
    • Multiple JCI-accredited centers (Sheba, Rambam 97.5%, Hadassah, Assuta, Soroka) with ISO 15189 certification at flagship facilities
    • World-leading digital pathology adoption: Clalit (14 hospitals, 53% market share), Hadassah, Assuta using Sectra enterprise solutions; Maccabi using Ibex AI for multi-tissue cancer detection since 2018
    • Medical tourists show 25.9% diagnosis revisions with treatment plan changes in all 14 revised cases, demonstrating clinical diagnostic value
    • Documented pathologist shortage: 267 total, ratio 1.96 per 100,000 (less than half US rate) with recent brain drain (~950 physicians in 2023-2024)
    • Blood culture quality study (2021-22) found only 40.7% of Israeli hospitals met basic <3% contamination standard and 23.5% of bloodstream infections undetected

    Read the full Israel report →

  6. 6 South Korea KR 4.5/5 Good South Korea demonstrates pathology quality between Good and Excellent, excelling in digital pathology leadership (Samsung HIMSS Stage 7, first globally), comprehensive proficiency testing (KEQAS since 1976, ISO 17043 ... Full report
    The evidence behind this score 6 cited points
    • Samsung Medical Center achieved HIMSS Stage 7 DIAM certification in February 2023, first healthcare provider globally; 5G-connected digital pathology reduced frozen section turnaround from 20 to 10 minutes
    • KEQAS operating continuously since 1976 with ISO 17043 certification (2015); 1,818 participants as of 2019 providing 69 EQA programs covering all laboratory disciplines
    • Cytopathology Quality Assurance Program achieved <0.2% unsatisfactory Pap test rate and <0.6% cytology-histology discrepancy among over 10 million annual examinations
    • Laboratories with KLAP accreditation exhibit significantly lower variance index scores compared to non-accredited labs (P<0.0001), demonstrating statistically proven quality improvement
    • Unique exclusively laboratory-medicine residency program producing ~600 certified clinical pathologists since 1963 with comprehensive training across hematology, immunology, microbiology, chemistry, genetics, and informatics
    • South Korea attracted 1.17 million foreign patients from 202 countries in 2024; first country worldwide to establish national medical tour coordinator licensing system (2013) with multilingual support in 10+ languages

    Read the full South Korea report →

  7. 7 Jordan JO 4.0/5 Good Jordan's pathology sector is anchored by world-class flagship institutions with multiple international accreditations (ISO 15189, CAP, JCI) and well-qualified pathologists holding American and UK board certifications.... Full report
    The evidence behind this score 5 cited points
    • MedLabs holds ISO 15189 (first in Jordan 2008), CAP (renewed 8 consecutive times through May 2025), ISO 9001, and HCAC; KHCC CAP-accredited since 2009; Abdali Hospital JCI-accredited (second consecutive cycle)
    • KHCC pathology chairman triple board-certified (US); Abdali pathology head holds RCPath fellowship (UK); JUST pathology residency ACGME-I accredited from July 2023
    • KHCC operates 6 specialized labs with 8 million annual tests, mandatory histology review, weekly tumor boards; MedLabs offers 1,000+ tests daily with 20 consultants and 600+ staff
    • Only 10% of cases diagnosed digitally despite 70% owning slide scanners; 72% of pathologists rarely use digital systems; 76.9% cite funding barriers
    • Jordan hosted 224,000 medical tourists in 2024; major hospitals have dedicated International Patient Departments with English and Russian support; costs 25-40% below US/Europe

    Read the full Jordan report →

  8. 8 Japan JP 4.0/5 Good Japan demonstrates strong pathology infrastructure with multiple laboratories holding international accreditations (CAP, ISO 15189) and sophisticated quality control systems (JCCLS enzyme CV <5-10%, comparable to Euro... Full report
    The evidence behind this score 5 cited points
    • National Cancer Center Hospital East holds ISO 15189 (2013), CAP (2022), ISO 9001:2015; SRL holds ISO 15189 at two facilities and CAP at five facilities; over 30 CAP-accredited labs total in Japan.
    • JCCLS nationwide quality control maintains enzyme measurement CV below 5-10% for AST, ALT, CK, LDH—comparable to best-performing European systems; NCCHE participates in CAP proficiency testing for IHC and cytopathology.
    • Japan holds 43.96% of Asia-Pacific digital pathology market share (2023); over 65% of installed WSI systems in public hospitals/universities; 60% of digital pathology spending on AI-enabled platforms.
    • Board certification requires 5 years training and annual examination; comprehensive molecular diagnostics (NGS, comprehensive genomic profiling) reimbursed since 2019; Expert Panels (Molecular Tumor Boards) at 162 designated hospitals.
    • 45 JMIP-accredited hospitals provide multilingual coordination; however, National Cancer Center requires Japanese-language communication capability for clinical interaction, requiring medical coordinators as intermediaries; pathology reports issued in Japanese.

    Read the full Japan report →

  9. 9 Brazil BR 4.0/5 Good Brazil's major accredited private hospitals—including Hospital Albert Einstein (CAP-certified since 2009), 25 JCI-accredited institutions, and emerging AI-driven platforms (Rede D'Or/PathAI partnership)—provide modern... Full report
    The evidence behind this score 5 cited points
    • 25 JCI-accredited hospitals in Brazil (highest in Latin America); Hospital Albert Einstein maintains CAP accreditation since 2009 and processes 1.2 million tests/month
    • Rede D'Or (78 hospitals) deploying PathAI AISight digital pathology platform with AI-assisted breast biomarker quantification, announced February 2025
    • PNCQ enrolls 5,028 laboratories across 63 proficiency testing schemes covering all 26 states, with mandatory external quality assessment under ANVISA's modernized RDC 786/2023
    • Pathologist shortage: 1.79 per 100,000 residents versus international benchmark of 5–6.5 per 100,000; 52.8% concentrated in Southeast; North region reports 88.5% deficit in anatomopathological exams
    • Comprehensive service capabilities at major centers including CAP-accredited NGS (Mendelics), immunohistochemistry, flow cytometry, frozen sections, and 82 multidisciplinary tumor boards in São Paulo oncology centers

    Read the full Brazil report →

  10. 10 Spain ES 4.0/5 Good Spain maintains multiple ISO 15189-accredited laboratories with several JCI-accredited hospitals, well-qualified pathologists trained through formal 4–5 year residency programs, and state-of-the-art equipment includin... Full report
    The evidence behind this score 6 cited points
    • Multiple laboratories hold ISO 15189 accreditation (Quirónsalud, Ribera Lab, CIMA LAB, Hospital de Bellvitge, Eurofins Megalab); several hospitals JCI-accredited
    • Spain at forefront of European digital pathology: DigiPatICS deploys 24 scanners across 8 hospitals processing >1 million slides/year; Hospital del Mar and Granada 100% digital
    • SEQCML external quality assurance shows 90% of labs meet biological variation specs; glucose analytical error 5.0% (better than France's 7.3%)
    • Comprehensive services with subspecialty depth: Hospital Clínic processes >700,000 tests/year; Hospital de Bellvitge documents 39,010 biopsies + molecular/immunohistochemistry capabilities
    • Good medical tourism infrastructure: HM Hospitales remote second-opinion within 48–72 hours; multilingual staff across major private networks; MD Anderson Madrid international pathology services
    • Workforce concerns documented: annual dropout rate >20% in pathology residencies; pathology ranks 34th of 45 specialties in resident preference

    Read the full Spain report →

  11. 11 United Kingdom GB 4.0/5 Good The United Kingdom demonstrates excellent pathology infrastructure with mandatory ISO 15189 accreditation across NHS laboratories, world-leading digital pathology networks (NPIC with 30+ hospitals), and internationall... Full report
    The evidence behind this score 5 cited points
    • Mandatory ISO 15189 accreditation enforced by UKAS across NHS laboratories; ~550 labs transitioning to updated ISO 15189:2022 standard with 50%+ completed as of May 2025
    • World's largest national digital pathology network (NPIC) operates 30+ hospitals scanning 3M+ images annually with £100M+ government investment since 2018
    • UK NEQAS operates globally-leading external quality assessment scheme with 1,500+ participating laboratories across 50+ countries and 50 years operational history
    • Royal College of Pathologists FRCPath qualification recognized internationally with training across 21 subspecialties; multiple centres offer subspecialty expertise (Royal Marsden, UCLH, Oxford, Great Ormond Street)
    • Strong private sector infrastructure for international patients: London Clinic, HCA Healthcare UK Laboratories, and Diagnexia all maintain ISO 15189:2022 accreditation with multilingual services and international result coordination

    Read the full United Kingdom report →

  12. 12 India IN 4.0/5 Good India demonstrates strong pathology infrastructure with multiple hospitals holding international accreditations (CAP, JCI) supported by a robust national NABL framework with APAC/ILAC mutual recognition. Pathologists ... Full report
    The evidence behind this score 5 cited points
    • NABL accreditation with APAC/ILAC mutual recognition for international test result acceptance; approximately 2,500+ NABL accredited laboratories; major chains (Dr. Lal PathLabs, SRL) hold dual NABL/CAP accreditation; 45 JCI-accredited hospitals
    • MD Pathology programs (3-year post-MBBS) through NEET-PG entrance; leading diagnostic chains employ 200+ senior pathologists and 2,000+ technicians; AIIMS Department published 200+ peer-reviewed papers in 2021 alone
    • State-of-the-art equipment in major centers: AIG Hospitals (80,000 sq ft, automated analyzers, pneumatic sample transport, IHC platforms), Tata Medical Center (6 automated IHC platforms from Leica/Roche/DAKO, laser capture microdissection, digital pathology system)
    • Quality assessment study showed 0.8% diagnostic error rate (99.2% accuracy) on 10% random review across multiple departments; comprehensive services including 4,000+ test profiles, molecular pathology, flow cytometry, immunofluorescence
    • Medical tourism infrastructure: international patient coordinators, multilingual staff, secure digital medical records with translation services, 24-hour customer care hotlines (365,000+ calls annually), home sample collection services

    Read the full India report →

  13. 13 Malaysia MY 4.0/5 Good Malaysia demonstrates good laboratory quality through robust SAMM accreditation aligned with MS ISO 15189:2022, including rare CAP-accredited reference laboratories. Pathologists meet international standards via MMC a... Full report
    The evidence behind this score 5 cited points
    • Multiple ISO 15189-accredited laboratories; Premier Integrated Labs holds quadruple accreditation (CAP, MS ISO 15189, MSQH, JCI), one of only two Malaysian CAP-accredited labs
    • SAMM mandates proficiency testing participation; Clinipath participates in RIQAS (2,500+ worldwide) and RCPA QAP for external benchmarking
    • Comprehensive molecular diagnostics available: NGS, FISH, immunohistochemistry, flow cytometry, liquid biopsies; 24 million annual tests
    • Pathologist qualifications governed by MMC with specialist recognition via CPath AMM; subspecialty fellowship training available with RCPA affiliation at HCTM/UKM
    • Strong medical tourism support: Sunway serves 113,000+ international patients from 170+ countries; Premier Integrated Labs accepts cross-border samples from 6 regional countries; secure online result portals (Telis Online, WebTrak); English-language reporting standard

    Read the full Malaysia report →

  14. 14 Thailand TH 4.0/5 Good Thailand achieves a strong 'Good' rating for pathology quality, anchored by flagship Bangkok private hospitals (Bumrungrad, Siriraj) with CAP international accreditation, state-of-the-art automation and molecular capa... Full report
    The evidence behind this score 6 cited points
    • Bumrungrad CAP-accredited since 2016 (first private Thai hospital); Siriraj CAP-accredited since November 2022 (first teaching hospital); 201 Thai medical laboratories ISO 15189-accredited by 2019 via BLQS-DMSc; BLQS holds full ILAC MRA signatory status
    • Bumrungrad operates 100+ specialists, 1,500+ test types, 3M+ tests annually with Total Laboratory Automation, AI blood cell analysis, Ion Torrent Genexus NGS; Siriraj One Barcode system reduced specimen turnaround from 50-55 minutes to 44 minutes
    • Royal College of Pathologists of Thailand at Institute of Pathology (since 1972); multiple university residency/fellowship programs; IAP-Thailand established 1959 with biannual digital-slide EQA proficiency testing
    • Comprehensive anatomical and clinical pathology services including subspecialties (hematopathology, cytopathology, renal, neuropathology, dermatopathology, molecular diagnostics) available at major hospitals
    • Thailand hosts 3.5M+ international medical visitors annually (first in Asia); Bumrungrad coordinates for 190 countries in 12+ languages; 65 JCI-accredited organisations as of 2026; English-language reporting standard; secure online result portals
    • 20-year oral and maxillofacial lesion concordance study found 69.34% clinico-pathological agreement (below high-income countries); only 8 of 29 Chiang Rai provincial laboratories achieved certification within study period; pre-analytical tissue handling concerns documented in Southeast Asia region

    Read the full Thailand report →

  15. 15 Hungary HU 3.5/5 Moderate Hungary demonstrates world-class pathology capabilities at academic centers (Semmelweis, National Institute of Oncology) and private facilities (SYNLAB, Medicover) with advanced molecular diagnostics, digital patholog... Full report
    The evidence behind this score 6 cited points
    • Mandatory ISO 15189 accreditation requirement for all medical laboratories (elite among European countries), though only 9 labs actually accredited as of December 2023—eight from SYNLAB Hungary, one other
    • Semmelweis University's 1st Department of Pathology recognized as one of Europe's leading pathological centres with 17+ subspecialties and NGS technology unique in Central Europe; National Institute of Oncology holds OECI Comprehensive Cancer Center accreditation (first in Central/Eastern Europe) and EMQN molecular diagnostics accreditation
    • 91% full diagnostic concordance (182/200 cases) with 0.5% critical error rate in Hungary-Sweden international telepathology validation study; National Molecular Tumor Board reviews 10–15 complex cases weekly with embedded quality governance
    • €11 million EU and €6.72 million Norwegian grants for digital pathology infrastructure modernization; Hungary headquarters 3DHISTECH, global digital pathology market leader with 1,500+ PANNORAMIC® scanners installed
    • Severe pathologist workforce shortage—approximately 200 pathologists across 80 hospital departments with extensive emigration (8,500 health professionals left Hungary in past decade); 2–4 week turnaround times documented in smaller public hospitals affecting medical tourist care timelines
    • Excellent medical tourism support at private facilities (Medicover ISO 9001 certified with multilingual staff; SYNLAB Budapest 4,000+ examination types with English reporting) but variable access and English-language support at public facilities; EESZT national eHealth system enables electronic result transmission to home-country physicians

    Read the full Hungary report →

  16. 16 Colombia CO 3.5/5 Moderate Colombia's pathology quality reflects a bifurcated system: elite JCI-accredited hospitals (6 total) in major cities offer modern equipment, international partnerships, and comprehensive services with 98.3% national pr... Full report
    The evidence behind this score 5 cited points
    • Only 2 CAP-accredited clinical laboratories (Clínica Imbanaco, Laboratorio Médico Las Américas) and 1 CAP-accredited anatomical pathology lab in the entire country, limiting international quality verification coverage
    • Pathologist shortage of 0.88 per 100,000 inhabitants versus North American benchmarks of 50–65 per million, with cancer diagnostic delays averaging 70–79 days indicating system-wide throughput strain
    • No formal subspecialty pathology fellowship programs; subspecialists rely on informal training and mentorship rather than structured credentials, limiting subspecialty diagnostic capacity
    • 6 JCI-accredited hospitals with modern equipment (MALDI TOF, automated immunohistochemistry, flow cytometry, molecular diagnostics), 98.3% satisfactory performance on national PCR proficiency testing, and established medical tourism offices with English support
    • GLORIA telepathology network in pilot phase (not yet operational at scale) and digital pathology infrastructure limited; national laboratory reports issued in Spanish only, requiring pre-arranged English translation

    Read the full Colombia report →

  17. 17 Mexico MX 3.5/5 Moderate Mexico demonstrates strong pathology capabilities at top-tier private hospitals with multiple international accreditations (ISO 15189, JCI, CAP) and advanced technology deployment, but significant quality variation un... Full report
    The evidence behind this score 5 cited points
    • 81 ISO 15189 accredited clinical laboratories and 4 blood banks (second in Americas), but accreditation is voluntary not mandatory
    • 9 JCI-accredited hospitals including Médica Sur with CAP certification and Mayo Clinic partnership demonstrating international quality standards
    • State-of-the-art equipment and AI/machine learning integration at major private hospitals, but unregulated small-scale labs pose quality control challenges
    • Top pathologists at elite facilities internationally trained in U.S./Canada/Europe, but only 15 of 165+ medical schools accredited by COMAEM indicating significant training variability
    • Documented infectious disease outbreaks among medical tourists (fungal meningitis, CRE infections) and lack of published diagnostic accuracy metrics for quality assessment

    Read the full Mexico report →

  18. 18 Turkey TR 3.5/5 Moderate Turkey demonstrates excellent pathology services at major medical tourism hospitals with strong JCI and ISO 15189 accreditations, modern equipment including digital pathology systems, and well-qualified pathologists w... Full report
    The evidence behind this score 5 cited points
    • 46 JCI-accredited health institutions (one of top 3 globally), but only 15 total laboratories with ISO 15189 accreditation out of thousands operating nationally
    • Leading hospitals (Acibadem, Memorial) have modern digital pathology systems and telepathology networks; pathologists at major centers trained internationally in USA, Germany, or UK
    • No published diagnostic accuracy data provided; external quality control is not mandatory and no national proficiency testing program exists
    • Major laboratories participate in 5 different proficiency testing programs with 82 PT modules, but participation is voluntary and concentrated at accredited hospitals
    • Medical tourism support strong (1.5M international patients in 2024) with airport facilities and translation services, but pathological analyses take 10 days to 3 months and reports available only in Turkish and English

    Read the full Turkey report →

  19. 19 Poland PL 3.0/5 Moderate Poland demonstrates capable academic and commercial laboratory infrastructure with world-class oncology pathology centers and strong regulatory modernization, but is severely constrained by a critical pathologist shor... Full report
    The evidence behind this score 6 cited points
    • Pathologist shortage: 1 per 84,000 citizens (worst in Europe); 72% of workforce over 50; only 130 of 230 residency positions filled annually
    • Accreditation: Only ~21/2,700 laboratories hold formal ISO 15189 accreditation; PCA accredits under PN-EN ISO 15189:2023-02 and is ILAC member
    • Quality metrics: 33% of manual EQA results and 12% of automated results fell outside target limits in national proficiency testing (2017-2019); leading centers participate in 50+ international EQA programs
    • Infrastructure strengths: Diagnostyka Group operates 156 labs with 150M+ tests/year; Warsaw Medical University has virtual pathology and electron microscopy; Bydgoszcz Oncology Centre offers FISH, flow cytometry, AI-assisted digital pathology
    • Medical tourism: English-speaking departments in major cities; SNOMED/WHO-coded reports; translation in 50+ languages; 40-70% cost savings; second-opinion rights legally protected
    • Regulatory modernization: 2022 Laboratory Medicine Law and 2023 Quality in Healthcare Act implemented; new pathology-specific accreditation standards finalized 2025

    Read the full Poland report →

Reading the field

What separates a good programme from a dangerous one

Every country above is graded against this published scale — the same 1–5 rubric for pathology quality, top to bottom. How we score →

  1. 5/5 Excellent

    - Multiple laboratories with international accreditation (ISO 15189, CAP, JCI) - Highly qualified pathologists with subspecialty training and international recognition - State-of-the-art laboratory equipment and digital pathology systems - Published diagnostic accuracy rates >99% with robust quality control systems - Comprehensive pathology services including advanced molecular diagnostics - Excellent medical tourism integration with multilingual reporting and international coordination - Active participation in international proficiency testing with superior performance - Strong regulatory oversight with frequent inspections and high compliance rates

  2. 4/5 Good

    - Most major laboratories hold national accreditation with some international recognition - Well-qualified pathologists meeting international training standards - Modern laboratory equipment with good automation and quality systems - Diagnostic accuracy rates >97% with established quality control protocols - Full range of standard pathology services with some subspecialty capabilities - Good medical tourism support with English reporting and patient communication systems - Regular proficiency testing participation with above-average performance - Adequate regulatory oversight with acceptable compliance rates

  3. 3/5 Moderate

    - Basic laboratory accreditation present but limited international recognition - Pathologists meet minimum qualification requirements with variable subspecialty training - Standard laboratory equipment with basic quality control systems - Diagnostic accuracy rates 95-97% with inconsistent quality metrics - Essential pathology services available but limited advanced testing capabilities - Basic medical tourism accommodation with some language barriers - Irregular proficiency testing participation with mixed performance results - Regulatory oversight present but with compliance gaps

  4. 2/5 Poor

    - Limited or outdated laboratory accreditation standards - Pathologist shortages or qualifications below international standards - Aging laboratory equipment with inadequate quality control systems - Diagnostic accuracy rates 90-95% with concerning error rates - Basic pathology services only, significant gaps in subspecialty areas - Poor medical tourism integration with communication and coordination problems - Minimal proficiency testing participation with below-average performance - Weak regulatory oversight with significant compliance issues

  5. 1/5 Very Poor / Unavailable

    - No meaningful laboratory accreditation or quality standards - Severe pathologist shortages or inadequate training/qualifications - Outdated or unreliable laboratory equipment - Diagnostic accuracy rates <90% or no quality metrics available - Very limited pathology services with frequent unavailability - No accommodation for medical tourists, language barriers, poor communication - No participation in quality assurance or proficiency testing programs - Minimal or absent regulatory oversight

The reports

The full country reports under this lens

Each destination we have assessed has a full, cited report — the detailed analysis behind its score. The verdict is free; the report is the depth.

Clinics & providers

The clinics our research names

Named hospitals, clinics and centres cited across these findings — each carrying the specialties our reports record. Follow one to the reports behind it.

References

The sources behind these assessments

The distinct sources cited across these published reports — every finding carries its own citations; this is the union, each linking back to the reports that lean on it.

  1. Untitled source resource.npl.co.uk/international_office/countries/pack_th.html Cited in Pathology Quality in Thailand
  2. Untitled source a2la.org/accreditation/clinical-testing Cited in Pathology Quality in United States
  3. Untitled source acreditacionensalud.org.co/noticias/la-fundacion-valle-del-lili-recibe-el-certificado-de-acreditacion-en-salud-con-excelencia Cited in Pathology Quality in Colombia
  4. Untitled source acreditacionensalud.org.co/noticias/tercer-ciclo-de-acreditacion-en-salud-para-el-hospital-pablo-tobon-uribe-de-la-ciudad-de-medellin Cited in Pathology Quality in Colombia
  5. Untitled source anab.ansi.org/accreditation/medical-lab-accreditation Cited in Pathology Quality in United States, Pathology Quality in Thailand
  6. Untitled source bangkokhealthservice.com/best-hospital-in-bangkok-for-foreigners Cited in Pathology Quality in Thailand
  7. Untitled source benoit-partners.com/medical-company Cited in Pathology Quality in Thailand
  8. Untitled source blqs.dmsc.moph.go.th/page-view/539 Cited in Pathology Quality in Thailand
  9. Untitled source discoverims.com Cited in Pathology Quality in Thailand
  10. Untitled source discoverinternationalmedicalservice.com Cited in Pathology Quality in Thailand
  11. Untitled source en.wikipedia.org/wiki/Clinical_Laboratory_Improvement_Amendments Cited in Pathology Quality in United States
  12. Untitled source en.wikipedia.org/wiki/Medical_tourism_in_South_Korea Cited in Pathology Quality in South Korea
  13. Untitled source en.wikipedia.org/wiki/National_Accreditation_Board_for_Testing_and_Calibration_Laboratories Cited in Pathology Quality in India
  14. Untitled source expatfinancial.com/expat-financial-resources/finding-international-medical-care-abroad/international-hospitals-by-region/international-hospitals-in-asia/hospitals-in-thailand-for-travelers-and-expats Cited in Pathology Quality in Thailand
  15. Untitled source files.tuseb.gov.tr/tuska/files/akreditasyon/2024-11-04-13-30-44.pdf Cited in Pathology Quality in Turkey
  16. Untitled source ghsindex.org/wp-content/uploads/2021/12/Thailand.pdf Cited in Pathology Quality in Thailand
  17. Untitled source globallawexperts.com/medical-device-quality-management-system-in-turkey Cited in Pathology Quality in Turkey
  18. Untitled source gomedii.com/blogs/english/doctors-hospitals/jci-accredited-hospitals-in-kolkata Cited in Pathology Quality in India
  19. Untitled source he01.tci-thaijo.org/index.php/bulletinAMS/article/view/59891 Cited in Pathology Quality in Thailand
  20. Untitled source healthyturkiye.com/medical-check-ups-turkey Cited in Pathology Quality in Turkey
  21. Untitled source ilac.org/latest_ilac_news/blqs-dmsc-signatory-status Cited in Pathology Quality in Thailand
  22. Untitled source info.cap.org/event-informational-resources/downloads/0033906_Siriraj%20Hospital_A4_Final.pdf Cited in Pathology Quality in Thailand
  23. Untitled source istanbullawyerfirm.com/blog/the-process-of-obtaining-a-medical-licence-for-foreigners-in-turkey Cited in Pathology Quality in Turkey
  24. Untitled source karetrip.com/blogs/support-services-for-international-patients-in-indian-hospitals Cited in Pathology Quality in India

Explore the source archive →

In plain language

Start exploring the knowledge base

The field's shorthand our reports use, sized by how often it comes up. Follow any term to its full entry and the reports that use it.

For readers weighing this decision

Ways to read the evidence

The verdict is always free. A membership opens the full analysis and every cited source — this specialty, the whole library, or everything for good.

  • One specialty · annual

    Diagnostic Services

    $49.00 / year

    $49.00/year

    Every report in this specialty — full analysis and every cited source — as each is published.

    Take this specialty

  • Full library · annual

    The whole library

    $199.00 / year

    $199.00/year

    The complete evidence behind every finding in every specialty, while your decision is live.

    Take the full library
  • Most readers

    Lifetime · one payment

    Everything, for good

    $499.00 once

    $499.00 (one-time)

    Every finding we publish today and hereafter — no renewal, no expiry. The tier we point most readers to.

    Take lifetime access

Prefer to pay per report? A single report is $29.00, yours to keep — browse the reports. The verdict is always free.

Where to go from here · Pathology Quality

no scope is a dead end — step up to the specialty, drill into a factor, or pivot across to a country or a comparison